JOHNSON DAVID LEE (Chief Operating Officer) sold 5.3% of their position (2.58K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $108.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/25/2026ACC: 0001733883-26-000006
Officer· Chief Operating Officer
Since Feb 2026
-2.58K
Net shares
Net seller
$108.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.58K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−2.58K
Price / share
$41.98
Trade value
$108.28K
% of position
5.3%
2/23/2026
48.31K→45.73K
Total
Net shares
−2.58K
Net value
-$108.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/23/2026 | S · Sale | −2.58K | $41.98 | $108.28K | 5.3% | 48.31K | 45.73K |
| Total | −2.58K | -$108.28K | ||||||
Derivative Transactions0
No derivative transactions reported